micronavigation ELN path item Network Services path item Infocenter path item Poll for Web-Advisor  · 
Workpackage

Poll for Web-Advisor

Created by: ihrig , generated 2009/02/16 , last changed: 2010/02/17

Web-Advisor for support home country Leukemia information

The ELN community is expanding over the years. This is also recognized by the public, as the website-vistis are rising. The website delivers useful information for patiens and physicians, all over Europe - which is outstanding for Leukemia indeed.
The popularity of the website could be easily improved and ELIC will support any member interested in being a contact person for the WP and the home country.

Engagement for patient information service for the home country

Country specific Web-Editor:

Web-Editor: The workload is very limited, e. g. google search. Also, a Web-Editor can be trained by using the content management system of the ELN-website, which is absolutely easy to handle. He or she can be contact person for ELIC regading information for the people of the home country. All participants will be named on the website and at the next ELN symposium.
For your information have a look here for the list of web-editors ("web-advisors") (date 2008).

General interest:

In general:
You think, we should pursue this issue in between the ELN?
Yes No

Suggestion for Web-Advisor

If you like, you can suggest a person, interested in web-techniques and patient information service

Web-Editor: Degree
Web-Editor: First Name
Web-Editor: Second Name
Web-Editor: Country
Web-Editor: E-Mail
Web-Editor: WP
Name of participant of the poll
Please give us your name and WP, if not listed above

After your feedback, we will contact the named persons and build up new functional structure of the ELN.
Thank your for your contribution.
If you have any comments beside, don't hesitate to contact
elic@leukemia-net.org


 

Print this Document   Sitemap   Contact  
EUTOS
European Leukemia Trial Registry (ELTR) More ...
EUTOS
EUTOS for CML is a unique collaboration between the European LeukemiaNet and Novartis Oncology in Europe More ...


 
top